Healthcare Media & Clinician Networks · MarTech Vendor · B2C Consumer App / Platform
Doximity
Clinician network and healthcare workflow platform monetised via enterprise tools.
Available information varies by company and source.
Profile record updated:
Company facts
- Official name
- Doximity, Inc.
- Entity type
- COMPANY
- Founded
- 2010
- Headquarters
- 500 3rd Street, Suite 510, San Francisco, California 94107
- Company size
- 501–1,000
- Market cluster / sector
- Healthcare Media & Clinician Networks
- Market role
- MarTech Vendor · B2C Consumer App / Platform
- Ticker
- DOCS
- Official website
- doximity.com
What Doximity does
Doximity operates a two-sided healthcare platform. On one side, it attracts and retains clinicians with free or freemium workflow utilities such as calling, messaging, telehealth, AI assistance, directories, and career tools. On the other side, it sells access, software, and engagement products to enterprise buyers that want to reach, recruit, or communicate with those clinicians. This creates value by combining audience aggregation, verified identity, workflow embedding, and healthcare-specific targeting within a single ecosystem.
Category differentiation
Doximity is a healthcare professional network and enterprise healthcare software platform, not the separate video calling product doxy.me. It is also not a pure telehealth provider like Teladoc, as its model spans advertising, recruiting, and clinician workflow software.
Strategic context
AI-supported assessment from the existing company research; distinguish interpretation from sourced facts.
Doximity is a US healthcare technology company centred on a verified clinician network and a portfolio of workflow, communication, recruiting, and marketing products. Its clinician-facing app bundles professional networking, secure communications, telehealth, fax, directory tools, medical content, and AI-assisted workflows for physicians and other healthcare professionals. Around that audience, the company sells software and access products to healthcare enterprises, including hospitals, health systems, recruiters, pharmaceutical companies, and medical marketers. The business monetises through a mix of enterprise subscriptions, contract-based software, recruitment products, and advertising or sponsored engagement sold to life sciences companies. Core value comes from controlling a trusted, clinician-only distribution layer in the US healthcare market, then using that audience and workflow position to sell communications, hiring, and marketing solutions to paying organisations while keeping many clinician tools free or freemium.
Company news briefing
Briefing updated:
Building on its clinical AI deployment, Doximity has partnered with Penn Highlands Healthcare to launch its Clinical AI Suite system-wide. This expansion follows strong fiscal first-quarter 2027 results, where the company reported revenue of $156.6 million and raised its full-year guidance to between $671 million and $681 million. This financial growth was underpinned by the strong monetisation of its new AI search product, which the company reports generates over ten times the revenue per search compared to its cost.
Business model & monetisation
The company uses a hybrid monetisation model. It offers free or freemium clinician tools to build usage and network density, then charges enterprise customers via subscription and contract-based SaaS for recruitment, hospital outreach, and communication products. It also sells advertising and sponsored engagement inventory to life sciences companies through its clinician audience, with additional clinician subscription revenue from premium workflow upgrades such as Dialer Pro.
- Life sciences marketing and advertising solutions
- Advertising and sponsored engagement sold against clinician audience
- Hospital and health system software contracts
- Subscription and enterprise SaaS agreements
- Recruitment and talent products
- Subscription and contract-based hiring tools
- Clinician premium upgrades
- Freemium conversion to paid subscription tiers
Products & capabilities
No products with linked sources are available in this view.
Unlock Full Intelligence Profile for Doximity
Get unlimited access to corporate ownership, historical M&A transactions, verified tech stack telemetry, and live market signals in the interactive Knowledge Graph.
Verified Ownership & Corporate Hierarchy
Complete corporate hierarchy traversal, shareholder cap table history, and parent holding links sourced from regulatory filings.
360° Tech Stack & Vendor Telemetry
Technical header bidding configurations, sellers.json registry nodes, CMP disclosures, and direct programmatic supply chains.
Live Market Signals & Executive Briefings
Continuous 24/7 monitoring of material M&A deals, executive shifts, product rollouts, and hiring trends across peer entities.
Competitors & alternatives
Track competitor shifts
Receive automated telemetry on strategic moves, acquisitions, and market share shifts across Doximity's competitive landscape.
Cloud communications and collaboration software for organisations and teams.
Healthcare booking and practice software platform for providers and patients.
Patient engagement and commerce software for medspas and clinics.
Healthcare adtech platform for pharma, publishers and HCP targeting.
Healthcare data and analytics platform for research and advertising.
Side-by-side comparisons
Recent recorded signals
Dates refer to the source publication. Older entries are historical context, not evidence of a new event.
Doximity Faces Securities Fraud Class Action Lawsuit
Legal/Regulatory · Recorded impact score: 2/5
Schall, Brown & Schwartz LLP (SBS) has announced a class action lawsuit against Doximity, Inc. (NYSE: DOCS) for alleged violations of Sections 10(b) and 20(a) of the Securities Exchange Act of 1934. The complaint claims Doximity made false and misleading statements, overstating the positive impact of its Newsfeed product on revenue growth and misleading investors about its advertising delivery methods, which included banner ads and newsletters. The class period is from August 8, 2024, to May 13, 2026, with a deadline of November 16, 2026, for investors to seek lead plaintiff appointment. Investors who purchased shares during this period may be eligible for recovery.
- SBS files class action lawsuit against Doximity for securities fraud violations.
- Class period: August 8, 2024 to May 13, 2026.
Novant Health Partners with Doximity to Bring Evidence-Based Clinical AI Into Epic
Recorded impact score: 4/5
Doximity announces new partnerships with Novant Health and Penn Highlands Healthcare to deploy its Clinical AI Suite, and releases the 2026 Physician Compensation Report highlighting AI fluency as a career advantage.
Penn Highlands Healthcare Partners with Doximity to Launch System-Wide Clinical AI Suite
Recorded impact score: 4/5
Doximity announces a partnership with Penn Highlands Healthcare to deploy its Clinical AI Suite system-wide.
Explore company relationships
Questions about Doximity
What is Doximity?
Doximity is a US healthcare technology company that operates a verified clinician network and sells workflow, recruiting, hospital, and life sciences marketing products.
Who uses Doximity?
Clinicians use its app and workflow tools, while hospitals, health systems, recruiters, pharmaceutical companies, and agencies buy its enterprise products.
How does Doximity make money?
It makes money through enterprise software subscriptions, recruitment products, hospital solutions, life sciences advertising and marketing spend, and some premium clinician upgrades.
Sources & coverage
This profile uses public, official and technically observable information. Missing information does not prove that a product or relationship does not exist. The list below does not imply that every profile statement has been verified.
17 publicly documented primary sources and citations linked across the market graph.
Continue your research on Doximity
Open additional company details, personal Watchlists and your Strategic Intelligence Agent in Polaris7. It monitors your market daily and delivers tailored briefings with clear strategic context whenever relevant news occurs.
Daily intelligent monitoring · Verified primary sources.
Unlock full intelligence profile, ownership & live market signals